Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
14.06
-1.49 (-9.58%)
May 14, 2025, 4:00 PM - Market closed

Korro Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
132357383--
Market Cap Growth
-77.36%-6.96%---
Enterprise Value
42229578--
Last Close Price
15.5538.0747.93--
PS Ratio
29.87157.04---
PB Ratio
1.052.222.26--
P/TBV Ratio
0.982.222.26--
EV/Sales Ratio
8.68100.98---
Debt / Equity Ratio
0.330.280.200.05-
Asset Turnover
0.020.01---
Quick Ratio
9.078.548.536.3523.95
Current Ratio
9.418.798.876.5624.20
Return on Equity (ROE)
-60.22%-50.60%-69.16%-62.24%-
Return on Assets (ROA)
-29.82%-25.65%-35.77%-36.63%-
Return on Capital (ROIC)
-32.13%-28.14%-38.98%-38.89%-
Earnings Yield
-64.44%-23.43%-21.18%--
FCF Yield
-55.32%-21.86%-19.60%--
Buyback Yield / Dilution
-167.19%-483.30%-499.32%94.26%-
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q